Skip to main content
. 2017 Oct 13;6(12):2787–2795. doi: 10.1002/cam4.1228

Figure 1.

Figure 1

Effects of Sorafenib on cell proliferation differ between HepG2 cells and HCC‐0010 cells. (A) Basal pERK levels in different cell lines were measured by western blotting. (B–D) The effects of Sorafenib on cell proliferation were measured by the CCK‐8 cell viability assay (mean±SEM; *P<0.05).